tradingkey.logo

Regencell Bioscience Holdings Ltd

RGC

12.280USD

-0.520-4.06%
Close 08/25, 16:00ETQuotes delayed by 15 min
6.07BMarket Cap
--P/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
Operating expenses
-14.74%2.42M
-32.59%2.31M
-28.16%2.84M
-6.27%3.43M
--3.96M
--3.66M
R&D expenses
151.23%581.48K
-64.10%484.75K
-83.43%231.46K
21.05%1.35M
--1.40M
--1.12M
Operating profit
14.74%-2.42M
32.59%-2.31M
28.16%-2.84M
6.27%-3.43M
---3.96M
---3.66M
Net non-operating interest income (expenses)
Other non-operating income (expenses)
155.03%247.54K
10.22%125.96K
319.71%97.06K
128303.37%114.28K
--23.13K
--89.00
Income before tax
20.74%-2.18M
34.07%-2.19M
30.20%-2.75M
9.39%-3.32M
---3.94M
---3.66M
Income tax
----
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
20.74%-2.18M
34.07%-2.19M
30.20%-2.75M
9.39%-3.32M
---3.94M
---3.66M
Net income from continuous operations
20.74%-2.18M
34.07%-2.19M
30.20%-2.75M
9.39%-3.32M
---3.94M
---3.66M
Net Income attributable to non-controlling interests
156.02%57.89K
-35.75%-119.27K
-27.19%-103.34K
-30.43%-87.86K
---81.25K
---67.36K
Net income attributable to controlling interests
15.45%-2.24M
35.97%-2.07M
31.41%-2.64M
10.14%-3.23M
---3.85M
---3.59M
Net income attributable to common shareholders
15.45%-2.24M
35.97%-2.07M
31.41%-2.64M
10.14%-3.23M
---3.85M
---3.59M
Basic earnings per share
15.45%-0.17
35.97%-0.16
32.50%-0.20
13.06%-0.25
---0.30
---0.29
Diluted earnings per share
15.45%-0.17
35.97%-0.16
32.50%-0.20
13.06%-0.25
---0.30
---0.29
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI